115 related articles for article (PubMed ID: 19719835)
21. Factors that influence activated CD8+ T-cell apoptosis in patients with acute herpesvirus infections: loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression.
Borthwick NJ; Bofill M; Hassan I; Panayiotidis P; Janossy G; Salmon M; Akbar AN
Immunology; 1996 Aug; 88(4):508-15. PubMed ID: 8881750
[TBL] [Abstract][Full Text] [Related]
22. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
23. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
24. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
26. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F
Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460
[TBL] [Abstract][Full Text] [Related]
27. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
28. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan.
Takebe H; Miki Y; Kozuka T; Furuyama JI; Tanaka K
Cancer Res; 1977 Feb; 37(2):490-5. PubMed ID: 832273
[TBL] [Abstract][Full Text] [Related]
29. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
[TBL] [Abstract][Full Text] [Related]
30. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical prognostic criteria in xeroderma pigmentosum.
Karakok M; Turkmen A; Bekerecioglu M; Koçer NE
Int J Dermatol; 2010 Nov; 49(11):1266-71. PubMed ID: 21038547
[TBL] [Abstract][Full Text] [Related]
32. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
Fischer E; Schnyder UW; Jung EG
Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma.
Sen F; Rassidakis GZ; Jones D; Medeiros LJ
Mod Pathol; 2002 Jun; 15(6):625-31. PubMed ID: 12065776
[TBL] [Abstract][Full Text] [Related]
34. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
Allal AS; Waelchli L; Bründler MA
Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
[TBL] [Abstract][Full Text] [Related]
36. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers.
Tomková H; Fujimoto W; Arata J
Eur J Dermatol; 1998 Jun; 8(4):256-60. PubMed ID: 9649682
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
[TBL] [Abstract][Full Text] [Related]
38. Atypical fibroxanthoma and squamous cell carcinoma of the conjunctiva in xeroderma pigmentosum.
Shao L; Newell B; Quintanilla N
Pediatr Dev Pathol; 2007; 10(2):149-52. PubMed ID: 17378688
[TBL] [Abstract][Full Text] [Related]
39. Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?
Gache Y; Brellier F; Rouanet S; Al-Qaraghuli S; Goncalves-Maia M; Burty-Valin E; Barnay S; Scarzello S; Ruat M; Sevenet N; Avril MF; Magnaldo T
PLoS One; 2015; 10(12):e0145369. PubMed ID: 26694869
[TBL] [Abstract][Full Text] [Related]
40. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.
Gaspari AA; Fleisher TA; Kraemer KH
J Clin Invest; 1993 Sep; 92(3):1135-42. PubMed ID: 7690772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
